Nick Daneman

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 248 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

Simin Florescu, Delia Stanciu, Mihaela Zaharia et al. · JAMA · 2022 · 137 citations · Full text

Medicine, Critical Care Nursing, Critical Care Medicine +6

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Yaseen M. Arabi, Anthony Gordon, Lennie Derde et al. · Intensive Care Medicine · 2021 · 100 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

Sheryl Ann Abdukahil, Ryuzo Abe, Laurent Abel et al. · Infection · 2021 · 80 citations · Full text

Public Health, Infectious Diseases, Pediatrics +9

Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study

Srinivas Murthy, Patrick Archambault, Anika Atique et al. · CMAJ Open · 2021 · 79 citations · Full text

Medicine, Infectious Diseases, Acute Care Medicine +13